Goldman Sachs Group Inc Cure Vac N.V. Put Options Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

May 14, 2024
BUY
$13.18 - $19.41 $263,600 - $388,200
20,000 New
20,000 $272,000
Q2 2022

Aug 15, 2022
SELL
$13.18 - $19.41 $1.05 Million - $1.55 Million
-80,000 Reduced 80.0%
20,000 $272,000
Q3 2021

Nov 10, 2021
BUY
$49.26 - $74.5 $4.93 Million - $7.45 Million
100,000 New
100,000 $5.46 Million

Others Institutions Holding CVAC

# of Institutions
98
Shares Held
14.4M
Call Options Held
241K
Put Options Held
419K
View Full List

About CureVac N.V.

CVAC Quotes by TradingView
  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $536M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email